01.04.2011 • NewsDow CorningWackerChina National BlueStar

China's BlueStar Wins EU Okay To Buy Orkla Unit

Chinese state-run chemicals company China National BlueStar secured EU regulatory approval on Friday to buy Norwegian conglomerate Orkla's silicon division Elkem for $2 billion.

The acquisition will give BlueStar, which is backed by U.S. private equity firm Blackstone Group, access to technology that could help China reduce its emissions of greenhouse gases.

The EU's competition chief Joaquin Almunia said in a statement: "Even assuming all Chinese state-owned firms in the sector acted as one, European consumers would still enjoy sufficient competition from other players serving the market."

Elkem, which produces high-grade silicon for the solar industry and computers, has production facilities in Europe, North and South America, Africa and Asia.
Other strong players serving European consumers include FerroAtlantica of Spain, Dow Corning of the United States and Germany's Wacker, the EU competition watchdog said.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.